Tagraxofusp – API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains [read full press release…]
Pharma Proff
Dasatinib – Drug Insight and Forecast, 2018
CITY, Country, 2019-Jul-17 — /EPR Network/ — Dasatinib (Sprycel) medicines are generally used to treat people with chronic myeloid leukemia and people with acute lymphoblastic [read full press release…]
Cabozantinib- API Insight, 2018
CITY, Country, 2019-Jul-17 — /EPR Network/ — Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid [read full press release…]
Myelodysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
CITY, Country, 2019-Jul-17 — /EPR Network/ — Myelodysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in [read full press release…]
Want to know positive clinical results of Akt/Protein Kinase B (PKB) Inhibitors?
CITY, Country, 2019-Jul-17 — /EPR Network/ — According to a new research report “Akt/Protein Kinase B (PKB) Inhibitors – Pipeline Analysis 2018, Clinical Trials & Results, Patents, [read full press release…]
Company’s key winning strategies will improve Uveal Melanoma in the future
CITY, Country, 2019-Jul-17 — /EPR Network/ — Uveal melanoma is the most common primary malignant tumour of intraocular malignancy, arises from melanocytes in the iris, [read full press release…]
Discover the detailed overview of Tuberous Sclerosis, highlighting the causes, risk factors, classification, prognosis, pathophysiology, unmet medical needs, diagnosis & treatment options- Pharma Proff
CITY, Country, 2019-Jul-17 — /EPR Network/ — Tuberous sclerosis, also known as tuberous sclerosis complex, is a genetic disorder characterized by the growth of numerous [read full press release…]
Keratitis Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Keratitis is an inflammatory eye disorder which affects cornea. It is mainly caused by virus, bacteria, amoebic, and [read full press release…]
Prurigo Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Prurigo is a group of skin diseases characterised by intensely pruritic, and difficult to treat. There are two [read full press release…]
Venous Leg Ulcers (VLUs) Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Venous leg ulcers (VLUs) are defined as open lesions between the knee and ankle joint. It is the [read full press release…]
Vitiligo Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Vitiligo is a type of autoimmune disorder which is characterized by white patches on skin. This is mainly [read full press release…]
Abdominal Pain Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Abdominal pain is a sensation of distress or discomfort in the abdominal region. Some common related condition that [read full press release…]
Behcet Disease (Behçet disease) Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Behcet Disease (Behçet disease) is an inflammatory disorder that affects blood vessels of various body parts including mouth, [read full press release…]
Brain-Derived Neurotrophic Factor (BDNF) Antagonist Therapeutics Pipeline Analysis 2018, Clinica
CITY, Country, 2019-Jul-16 — /EPR Network/ — Brain-derived neurotrophic factor (BDNF) is a type of nerve growth factor that stimulates the survival of dorsal root [read full press release…]
Biosimilars Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Biosimilar are biological products that show similar biological action as the U.S. Food and Drug Administration (USFDA) approved [read full press release…]
Cannabinoids Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Cannabinoid is a type of alkaloid that is obtained from the cannabis sativaplants. Cannabis, also known as marijuana, [read full press release…]
Cell Therapy Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Cell therapy is a type of therapy in which living cells are administered into a patient’s body for [read full press release…]
Chimeric Antigen Receptor T (CAR T) Therapy Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Chimeric antigen receptor T (CAR T) therapy is designed with a single signaling domain. CAR T therapy is [read full press release…]
Gene Therapy Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Gene therapy is a technique that involves treatment or prevention of a disease by using genes. Several methodologies [read full press release…]
Lipids Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Lipids are the large and miscellaneous group of organic compounds that are characterized by its solubility in non-polar [read full press release…]
